SG11201601477VA - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
SG11201601477VA
SG11201601477VA SG11201601477VA SG11201601477VA SG11201601477VA SG 11201601477V A SG11201601477V A SG 11201601477VA SG 11201601477V A SG11201601477V A SG 11201601477VA SG 11201601477V A SG11201601477V A SG 11201601477VA SG 11201601477V A SG11201601477V A SG 11201601477VA
Authority
SG
Singapore
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
SG11201601477VA
Inventor
Maharaj K Sahib
Jeetendra Kashinath Ambulge
Original Assignee
Wockhardt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wockhardt Ltd filed Critical Wockhardt Ltd
Publication of SG11201601477VA publication Critical patent/SG11201601477VA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
SG11201601477VA 2013-09-30 2014-09-29 Pharmaceutical composition SG11201601477VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN3124MU2013 IN2013MU03124A (en) 2013-09-30 2014-09-29
PCT/IB2014/064922 WO2015044922A1 (en) 2013-09-30 2014-09-29 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
SG11201601477VA true SG11201601477VA (en) 2016-04-28

Family

ID=51903957

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201601477VA SG11201601477VA (en) 2013-09-30 2014-09-29 Pharmaceutical composition

Country Status (10)

Country Link
US (1) US20160271226A1 (en)
EP (1) EP3052114A1 (en)
JP (1) JP2016531847A (en)
CN (1) CN105579052A (en)
AU (1) AU2014326181A1 (en)
BR (1) BR112016006963A2 (en)
IN (1) IN2013MU03124A (en)
RU (1) RU2016107610A (en)
SG (1) SG11201601477VA (en)
WO (1) WO2015044922A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108712910A (en) * 2016-02-25 2018-10-26 沃克哈特有限公司 The pharmaceutical composition of insulin and amino acid
CN106729639B (en) * 2017-01-10 2018-02-27 鲁南制药集团股份有限公司 A kind of insulin glargine injecta and preparation method thereof
ES2917893T3 (en) 2017-07-27 2022-07-12 Adocia Compositions in the form of an injectable aqueous solution comprising at least A21G human insulin and a glucagon suppressor with prandial action
US20220280614A1 (en) * 2019-08-02 2022-09-08 Case Western Reserve University Premixed Ultra-Stable Single-Chain Insulin Analogue Formulations
EP3915572A1 (en) * 2020-05-29 2021-12-01 Adocia Pharmaceutical composition in the form of an injectable aqueous solution including at least a rapid acting insulin analog and a glucagon suppressor with prandial action
EP3915571A1 (en) * 2020-05-29 2021-12-01 Adocia Pharmaceutical composition in the form of an injectable aqueous solution including at least a rapid acting insulin analog and a glucagon suppressor with prandial action

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3316363A1 (en) 1983-05-05 1984-11-08 Deutsche Babcock Anlagen Ag, 4200 Oberhausen ROLLER GRID FOR WASTE COMBUSTION PLANTS
PH25772A (en) 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
DK257988D0 (en) 1988-05-11 1988-05-11 Novo Industri As NEW PEPTIDES
HUT56857A (en) 1988-12-23 1991-10-28 Novo Nordisk As Human insulin analogues
PT93057B (en) 1989-02-09 1995-12-29 Lilly Co Eli PROCESS FOR THE PREPARATION OF INSULIN ANALOGS
DK155690D0 (en) 1990-06-28 1990-06-28 Novo Nordisk As NEW PEPTIDES
AU2003218635A1 (en) * 2002-05-07 2003-11-11 Novo Nordisk A/S Soluble formulations comprising insulin aspart and insulin detemir
CN101237854B (en) * 2005-05-23 2013-03-27 Sdg公司 Lipid construct for delivery of insulin to a mammal
DK3391876T3 (en) * 2005-05-23 2021-06-14 Sdg Inc Lipid construct for delivering insulin to a mammal
US8084420B2 (en) 2005-09-29 2011-12-27 Biodel Inc. Rapid acting and long acting insulin combination formulations
US20070086952A1 (en) 2005-09-29 2007-04-19 Biodel, Inc. Rapid Acting and Prolonged Acting Inhalable Insulin Preparations
US7713929B2 (en) * 2006-04-12 2010-05-11 Biodel Inc. Rapid acting and long acting insulin combination formulations
CN101454019A (en) * 2006-04-12 2009-06-10 百达尔公司 Rapid acting and long acting insulin combination formulations
EP2012817A2 (en) 2006-04-12 2009-01-14 Biodel, Inc. Rapid acting and long acting insulin combination formulations
EP2178909B1 (en) * 2007-08-13 2015-10-21 Novo Nordisk A/S Rapid acting insulin analogues
JP2010535842A (en) 2007-08-13 2010-11-25 ノボ・ノルデイスク・エー／エス Fast-acting insulin analogue
WO2011094632A1 (en) 2010-01-29 2011-08-04 The Uab Research Foundation Method for administration of insulin and pharmaceutical composition thereof
EP2651432A1 (en) * 2010-12-14 2013-10-23 Novo Nordisk A/S Fast-acting insulin in combination with long-acting insulin
CN103889442B (en) 2011-08-10 2016-12-28 阿道恰公司 The Injectable solution of at least one basal insulin

Also Published As

Publication number Publication date
WO2015044922A1 (en) 2015-04-02
US20160271226A1 (en) 2016-09-22
JP2016531847A (en) 2016-10-13
AU2014326181A1 (en) 2016-03-17
BR112016006963A2 (en) 2017-08-01
CN105579052A (en) 2016-05-11
EP3052114A1 (en) 2016-08-10
IN2013MU03124A (en) 2015-07-31
RU2016107610A (en) 2017-11-03

Similar Documents

Publication Publication Date Title
IL288961A (en) Pharmaceutical compositions
PT3030262T (en) Combined pharmaceutical composition
PL2943181T3 (en) Pharmaceutical compositions
GB201322602D0 (en) Pharmaceutical compounds
GB201306610D0 (en) Pharmaceutical compounds
PL3043778T3 (en) Pharmaceutical compositions containing refametinib
HK1213182A1 (en) Pharmaceutical composition for external application
ZA201408333B (en) Pharmaceutical compositions
IL244380A0 (en) Pharmaceutical compounds
EP2990038A4 (en) Solid pharmaceutical composition
SG11201601477VA (en) Pharmaceutical composition
GB201312386D0 (en) Pharmaceutical compounds
HRP20171888T1 (en) Pharmaceutical compositions
HUP1300496A2 (en) Stable pharmaceutical composition
HK1220143A1 (en) Pharmaceutical composition
GB201304699D0 (en) Pharmaceutical compositions
GB201304625D0 (en) New pharmaceutical composition
GB201321497D0 (en) Pharmaceutical compositions
GB201312851D0 (en) Pharmaceutical compositions
GB201316662D0 (en) Pharmaceutical Combination
GB201310496D0 (en) Pharmaceutical combinations
GB201317166D0 (en) Pharmaceutical compounds
GB201316791D0 (en) Pharmaceutical Compounds
GB201316780D0 (en) Pharmaceutical compounds
GB201315734D0 (en) Pharmaceutical compounds